Illumina, Inc. vs Merck & Company, Inc. — Stock Comparison

ILMN
Illumina, Inc.
$135.78
▲ 7.13%
vs
MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
Q·Score Winner
Illumina, Inc.
ILMN6.9/10vs 6.7/10

Q·Score Breakdown

6.9
Neutral
Overall
6.7
Neutral
8.5
Quality
6.2
7.6
Health
7
6.3
Growth
6.2
6
Valuation
7.2
5.2
Sentiment
7.1
ILMN

High-quality business with 34% return on equity and 19% profit margins.

analyst sentiment is cautious.

MRK

Forward P/E of 11.5× is low relative to sector peers.

Analyst Consensus

HOLD
Target $138.94 (+2.3%)
17 analysts
BUY
Target $129.74 (+15.7%)
27 analysts

Fundamentals

ILMN
MRK
24.7×
Trailing P/E
31.5×
23.0×
Forward P/E
11.5×
19.4%
Profit Margin
13.6%
68.4%
Gross Margin
76.6%
33.8%
ROE
4.8%
Revenue Growth
4.9%
6.1%
Earnings Growth
1.49
Beta
0.28
Price / Book
$20.6B
Market Cap
$277.0B
$74 – $156
52-Week Range
$73 – $125

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →